This 1.5-hour, live-virtual course is part of an online case-based learning collaborative series and focuses on a multidisciplinary approach to assessing opioid withdrawal syndrome.

This 1.5-hour, live-virtual course is part of an online case-based learning collaborative series and focuses on strategies to effectively manage medetomidine-opioid withdrawal syndrome.

The Benzodiazepine Tapering Considerations in General Medicine: Implementing The Joint Clinical Practice Guideline is a 4-hour course that translates the Joint Clinical Practice Guideline on Benzodiazepine Tapering into practical strategies for safer tapering.

This 88-hour on-demand conference includes 64 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

This 75-minute on-demand session from the ASAM 57th Annual Conference addresses advanced alcohol withdrawal management through case-based learning, covering validated assessment tools and treatment strategies for complex presentations.

This 1.5-hour, recorded course is part of an online case-based learning collaborative series and focuses on managing complicated opioid withdrawal in the Emergency or Hospital Setting.

This 75-minute on-demand session from the ASAM 57th Annual Conference addresses developing inpatient addiction consult services at pediatric institutions, exploring core components, stakeholder engagement, and implementation strategies.

This 1 hour and 45-minute on-demand session from the ASAM 57th Annual Conference addresses benzodiazepine management in outpatient settings, applying ASAM guidelines to cases and exploring tapering strategies and success definitions.

This 60-minute on-demand session from the ASAM 57th Annual Conference addresses gas station accessible substances including tianeptine, phenibut, and alkyl nitrites, covering toxidromes, complications, and harm reduction strategies.

This 75-minute on-demand session from the ASAM 57th Annual Conference addresses innovative medication initiation strategies for opioid use disorder, exploring novel buprenorphine, methadone, and naltrexone approaches for synthetic opioids.